COVID-19(11) SARS-CoV-2(4) Vaccines(3) coronavirus(3) immunoglobulins(3) antibodies(3) mRNA BNT162b2(3) Evidence(2) World Health Organization(2) Coronavirus disease 2019(2) Trial(2) heterogeneous(2) Sepsis(2) limit(2) determine(2) Probability(2) Still(2) Antimicrobial therapy(2) nucleic acid amplification techniques(2) trials(2) leads(2) coronavirus disease(2) Clinical data(2) Biomarkers(2) procalcitonin(2) PCT(2) can be used(2) clinical outcomes(2) key consideration(2) Patient(2)